drugset / Trial / NCT01251354
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the protocol is to determine the effect of BN83495 on the progression of endometrial cancer with estrogen receptor in post menopausal women who had previously received chemotherapy.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-06
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irosustat | Small molecule | 40 mg | Oral |